Jo Ann Blythe
Acute Care · Macon, GANPI 1104303171
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 177 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 177 payments — averaging $29.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$1K
- Kerecis Limited$668
- Amgen$341
- Takeda Pharmaceuticals U.S.A., Inc.$336
- Organogenesis Inc.$298
- AbbVie$281
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,184100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 22 | $1,002 |
| Kerecis Limited | 5 | $668 |
| Amgen | 16 | $341 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $336 |
| Organogenesis Inc. | 4 | $298 |
| AbbVie | 19 | $281 |
| UCB, Inc. | 17 | $268 |
| Merck | 13 | $260 |
| Viiv Healthcare Company | 11 | $235 |
| Johnson & Johnson | 13 | $234 |
| Melinta Therapeutics, LLC | 6 | $218 |
| Convatec Inc. | 4 | $209 |
| Cumberland Pharmaceuticals, Inc. | 3 | $138 |
| Mimedx Group, Inc. | 1 | $120 |
| Aurinia Pharma U.S., Inc. | 6 | $98 |
| CSL Behring | 3 | $74 |
| Smith+Nephew | 3 | $58 |
| Shionogi Inc | 3 | $56 |
| Bioventus LLC | 2 | $40 |
| GSK | 2 | $36 |
| Ultragenyx Pharmaceutical Inc. | 2 | $30 |
| Sanofi | 1 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
| Grifols USA, LLC | 1 | $23 |
| Solventum Corporation | 1 | $23 |
| Pfizer | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| La Jolla Pharmaceutical Company | 1 | $17 |
| Mayne Pharma Commercial LLC | 1 | $13 |
| Astellas Pharma US Inc | 1 | $13 |
| KCI USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$1,218
- Kerecis Omega3 Marigen$1,034
- Kerecis Omega3 GraftGuide$563
- Biktarvy$220
- Affinity$136
- InnovaMatrix AC$136
- Vibativ$133
- Rezzayo$124
- Puraply Antimicrobial$112
How this compares
$5,200 in reported general payments places this provider in the 95th percentile of 679 acute care providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 20 | $3,957 |
| Piperacillin-TazobactamPiperacillin Sodium/Tazobactam | 12 | $3,095 |
Paid to pharmacies, not to this prescriber.
Other acute care in Macon
- Enrique ValenciaMacon$5K
- Holly GoodmanMacon$4K
- Darryl TurnerRinggold$21K
- Bryce CowgillCumming$16K
- Stacy CreelSavannah$15K
- Susan BeitzellAthens$13K
- Crystal KuhnCumming$12K
- Mark ClarkGainesville$10K
- Sarah WymanAtlanta$10K
- Jeffrey DillerAustell$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.